Analysts Provide Their Views On Tscan Therapeutics Inc (TCRX)
Tscan Therapeutics Inc (NASDAQ:TCRX) concluded the trading at $4.77 on Wednesday, November 27, with a rise of 2.80% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $4.64 and 5Y monthly beta